UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Surface plasmon resonance-based competition assay to assess the sera reactivity of variants of humanized antibodies

Journal of immunological methods, 2002-10, Vol.268 (2), p.197-210

2002

Volltextzugriff (PDF)

SDR grafting—a new approach to antibody humanization

Methods (San Diego, Calif.), 2005-05, Vol.36 (1), p.25-34

2005

Volltextzugriff (PDF)

Construction, Affinity Maturation, and Biological Characterization of an Anti-tumor-associated Glycoprotein-72 Humanized Antibody

The Journal of biological chemistry, 2006-03, Vol.281 (11), p.6985-6992

2006

Volltextzugriff (PDF)

Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

Blood, 2005-04, Vol.105 (7), p.2862-2868

2005

Volltextzugriff (PDF)

SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity

Molecular immunology, 2004-07, Vol.41 (9), p.863-872

2004

Volltextzugriff (PDF)

Minimizing the Immunogenicity of Antibodies for Clinical Application

Tumor biology, 2005-01, Vol.26 (1), p.31-43

2005

Volltextzugriff (PDF)

In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: Isolation and characterization of minimally immunogenic high-affinity variants

Clinical cancer research, 2003-11, Vol.9 (15), p.5521-5531

2003

Volltextzugriff (PDF)

Grafting of "Abbreviated" Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody

The Journal of immunology (1950), 2002-09, Vol.169 (6), p.3076-3084

2002

Volltextzugriff (PDF)

Developing a minimally immunogenic humanized antibody by SDR grafting

Methods in molecular biology (Clifton, N.J.), 2004, Vol.248, p.361

2004

Volltextzugriff (PDF)

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor

Human gene therapy, 1999-01, Vol.10 (2), p.165-173

1999

Volltextzugriff (PDF)

Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (23 Suppl), p.5957s-5967s

1995

Volltextzugriff (PDF)

A CDR-grafted (humanized) domain-deleted antitumor antibody

Cancer biotherapy & radiopharmaceuticals, 1997-10, Vol.12 (5), p.305-316

1997

Volltextzugriff (PDF)

In vivo gene inoculation of a recombinant single-chain antitumor antibody induces anti-immunoglobulin response

Cancer gene therapy, 1997-07, Vol.4 (4), p.253-259

1997

Volltextzugriff (PDF)

Crystallographic studies and primary structure of the antitumor monoclonal CC49 Fab

Proteins, structure, function, and bioinformatics, 1993-12, Vol.17 (4), p.438-443

1993

Volltextzugriff (PDF)

A human T cell line engineered to secrete chimeric monoclonal antibody

Journal of immunotherapy with emphasis on tumor immunology, 1993-04, Vol.13 (3), p.143

1993

Volltextzugriff (PDF)

Transfer of the IL-6 gene into a human colorectal carcinoma cell line and consequent enhancement of tumor antigen expression

Immunology letters, 1993-05, Vol.36 (2), p.179-185

1993

Volltextzugriff (PDF)

Multivalent single-chain antibodies for radioimaging of tumors

The Journal of nuclear medicine (1978), 2001-10, Vol.42 (10), p.1528-1529

KASHMIRI, Syed V. S

2001

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Surface plasmon resonance-based competition assay to assess the sera reactivity of variants of humanized antibodies

SDR grafting—a new approach to antibody humanization

Construction, Affinity Maturation, and Biological Characterization of an Anti-tumor-associated Glycoprotein-72 Humanized Antibody

Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity

Minimizing the Immunogenicity of Antibodies for Clinical Application

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA : Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers

In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: Isolation and characterization of minimally immunogenic high-affinity variants

Grafting of "Abbreviated" Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody

Developing a minimally immunogenic humanized antibody by SDR grafting

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor

Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins

A CDR-grafted (humanized) domain-deleted antitumor antibody

In vivo gene inoculation of a recombinant single-chain antitumor antibody induces anti-immunoglobulin response

Crystallographic studies and primary structure of the antitumor monoclonal CC49 Fab

A human T cell line engineered to secrete chimeric monoclonal antibody

Transfer of the IL-6 gene into a human colorectal carcinoma cell line and consequent enhancement of tumor antigen expression

Multivalent single-chain antibodies for radioimaging of tumors

Suchergebnisse filtern